… Evidence-based management of anticoagulant therapy: antithrombotic therapy and
prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based …

This chapter is devoted to antithrombotic therapy for peripheral artery occlusive disease as
part of the American College of Chest Physicians Evidence-Based Clinical Practice …

Background Objective testing for DVT is crucial because clinical assessment alone is
unreliable and the consequences of misdiagnosis are serious. This guideline focuses on the …

Background The use of anticoagulant therapy during pregnancy is challenging because of
the potential for both fetal and maternal complications. This guideline focuses on the …

Background Correctly staging lung cancer is important because the treatment options and
prognosis differ significantly by stage. Several noninvasive imaging studies and invasive tests …

This article describes the pharmacology of approved parenteral anticoagulants. These include
the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight heparins …

Background This guideline updates the second edition and addresses patients with particular
forms of non-small cell lung cancer that require special considerations, including Pancoast …

… the combination of a compatible clinical picture and the presence of platelet-activating
anti-PF4 antibodies. Clinical prediction rules to assist physicians with determining the probability …

Background This section of the guidelines is intended to provide an evidence-based approach
to the preoperative physiologic assessment of a patient being considered for surgical …

This article provides the rationale for the approach to making recommendations primarily
used in four articles of the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: …